Jacobio Pharmaceuticals Group Co., Ltd. Share Price
Equities
1167
KYG4987A1094
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 HKD | -4.08% | +3.30% | -48.07% |
Sales 2024 * | - | Sales 2025 * | 60.31M 8.33M 65.03M 656M | Capitalization | 1.38B 191M 1.49B 15.01B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 462M 63.9M 499M 5.03B | Net cash position 2025 * | 703M 97.1M 758M 7.64B | EV / Sales 2025 * | 11.2 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 301 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.92% |
1 day | -4.08% | ||
1 week | +3.30% | ||
Current month | +11.24% | ||
1 month | +29.66% | ||
3 months | -18.26% | ||
6 months | -56.38% | ||
Current year | -48.07% |
Managers | Title | Age | Since |
---|---|---|---|
Yin Xin Wang
CEO | Chief Executive Officer | 59 | 31/05/18 |
Hai Jun Wang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 54 | 15/07/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rui Lin Song
BRD | Director/Board Member | 61 | 19/08/20 |
Xiaojie Wang
ADM | Chief Administrative Officer | 60 | 30/07/18 |
Yun Yan Hu
BRD | Director/Board Member | 61 | 30/07/18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.85% | 4 M€ | -27.92% |
Date | Price | Change | Volume |
---|---|---|---|
21/05/24 | 1.88 | -4.08% | 1,035,600 |
20/05/24 | 1.96 | +4.81% | 1,489,200 |
17/05/24 | 1.87 | +1.08% | 1,096,800 |
16/05/24 | 1.85 | +1.65% | 972,600 |
14/05/24 | 1.82 | +1.11% | 1,405,500 |
Delayed Quote Hong Kong S.E., May 21, 2024 at 09:08 am
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.07% | 199M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- 1167 Stock